SeraCare Life Sciences, Inc. Introduces New Executives
Published: Apr 24, 2012
“SeraCare already delivers the ingredients necessary to build accurate diagnostic tests and optimize the performance of laboratory assays,” said Charlie Mamrak, chief executive officer at SeraCare. “This company sits at the edge of an immense industry shift and is well positioned to become a driving force behind precision medicine. I am extremely excited to join SeraCare and help steer the organization through this growth.”
Fran Lunger, former CEO of Millipore Corporation, has been named SeraCare Board Chairman while Bill Drehkoff and Brian Miller of Linden, LLC will also join the SeraCare Board. Prior to joining SeraCare, Mr. Mamrak was CEO of PML Microbiologicals, a leading provider of prepared culture media, stains, reagents, quality control organisms, sterility products and collection systems. Mr. Ingalls brings more than 20 years experience in senior management including president and CEO of the start-up stem cell tools company ArunA Biomedical and positions as CFO of Premier Exhibitions and CardioMEMS.
About SeraCare Life Sciences, Inc.
SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics. The Company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.